GB News 46.86 Greatbatch (GB)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Greatbatch (GB) 46.86 $GB

Interim Clinical Study Results, Leadership Appointments, and Earnings Release Schedules - Analyst Notes on Merck, Magellan, ABIOMED, CONMED, and Greatbatch
PR Newswire - Tue Apr 15, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Merck & Co., Inc. (NYSE: MRK), Magellan Health Services Inc. (NASDAQ: MGLN), ABIOMED, Inc. (NASDAQ: ABMD), CONMED Corporation (NASDAQ: CNMD), and Greatbatch, Inc. (NYSE: GB). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1143-100free

Balanced View on Greatbatch - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 9:10AM CDT
GB expects to grow through its efforts to develop innovative medical devices and build a healthy product pipeline

Four Apple Suppliers To Watch As IPhone 6 Launch Approaches
at The Street - Wed Apr 02, 3:24PM CDT
Chris Lau, Kapitall: AAPL isn't the only play to take advantage of the iPhone 6. These Apple suppliers are worth [...]

Greatbatch, Inc. to Host Q1 2014 Earnings Conference Call
GlobeNewswire - Mon Mar 31, 3:05PM CDT
Greatbatch, Inc. (NYSE:GB) announced today that it will host a conference call on Wednesday, April 30, 2014 at 5:00 p.m. E. T. to discuss its financial results for the first quarter 2014 ended April 4, 2014.

Medical Device Manufacturing Services Outsourcing Report 2014-2018 with Accellent, Creganna-Tactx Medical, Greatbatch, Flextronics Dominating
M2 - Thu Mar 13, 10:33AM CDT
Research and Markets (http://www.researchandmarkets.com/research/9v4tlj/global_medical) has announced the addition of the "Global Medical Device Manufacturing Services Outsourcing Market 2014-2018" report to their offering. Outsourcing of medical device manufacturing services to emerging countries is a growing trend in the market. By outsourcing, leading medical devices companies not only take advantage of reduced costs but also position themselves to better serve the local markets of emerging countries. Reduced cost of labor, a high level of technical expertise, and funding from governments for R&D investment to accelerate new product development in emerging countries such as China, India, Malaysia, Mexico, and Brazil have made them the most favored destinations for outsourcing manufacturing services. Hence, outsourcing to emerging countries is expected to drive the Global Medical Device Manufacturing Services Outsourcing market during the forecast period. According to the report, one of the main drivers in this market is the advancements in healthcare technologies, which is causing the development of more complex medical devices contributing to the growth of the market. Further, the report states that one of the major challenges in the market is stringent regulatory guidelines that need to be adhered to by outsourcing services providers for quality control and meet environmental requirements. The key vendors dominating this market space are: - Accellent Inc. - Creganna-Tactx Medical - Greatbatch Inc. - Flextronics International Ltd. Key Topics Covered: 01. Executive Summary 02. List of Abbreviations 03. Scope of the Report 04. Market Research Methodology 05. Introduction 06. Market Landscape 07. Market Segmentation by Services 08. Geographical Segmentation 09. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Trends and their Impact 16. Vendor Landscape 17. Key Vendor Analysis For more information visit http://www.researchandmarkets.com/research/9v...al_medical

Greatbatch, Inc. Issues Voluntary Field Corrective Action for Standard Offset Cup Impactor
Business Wire - Tue Mar 11, 11:07AM CDT
On January 29, 2014, Greatbatch, Inc. initiated a voluntary field corrective action for all Standard Offset Cup Impactors after an internal review determined that the sterilization recommendation in the Instructions for Use for the product did not meet requirements for sterility assurance, which has the potential to result in surgical infection. No incidents have been reported during clinical use of the product, nor have there been any reported adverse events.

Greatbatch Q4 Earnings Lag by a Penny - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 26, 12:20PM CST
Net revenues in the quarter improved 11.0% (13% on an organic constant currency basis) to $176.6 million, which was almost in line with the Zacks Consensus Estimate of $176.0 million

Research and Markets: Concise Analysis of the International Food Emulsifiers Market Report
Business Wire - Tue Feb 25, 6:44AM CST
Research and Markets (http://www.researchandmarkets.com/research/434qhg/food_emulsifiers) has announced the addition of the "Concise Analysis of the International Food Emulsifiers Market Report" report to their offering.

Greatbatch, Inc. Reports 2013 Fourth Quarter and Full Year Results
Business Wire - Mon Feb 24, 3:10PM CST
Greatbatch, Inc. (NYSE:GB), today announced results for its fourth quarter and full-year ended January 3, 2014 highlighted by 5% constant currency organic revenue growth for the full year 2013; 12% year over year improvement in adjusted operating income; and 19% improvement in adjusted diluted EPS over 2012.

Research and Markets: 2014 Strategies for the Hepatitis Markers Diagnostic Testing Market
Business Wire - Fri Feb 14, 6:12AM CST
Research and Markets (http://www.researchandmarkets.com/research/xmb9dv/2014_strategies) has announced the addition of the "2014 Strategies for the Hepatitis Markers Diagnostic Testing Market" report to their offering.

Greatbatch Has Returned 18.8% Since SmarTrend Recommendation (GB)
Comtex SmarTrend(R) - Mon Feb 03, 9:55AM CST
SmarTrend identified an Uptrend for Greatbatch (NYSE:GB) on October 16th, 2013 at $35.46. In approximately 4 months, Greatbatch has returned 18.77% as of today's recent price of $42.11.

Greatbatch, Inc. to Host 2013 Earnings Conference Call
GlobeNewswire - Mon Jan 27, 8:43AM CST
Greatbatch, Inc. (NYSE:GB) announced today that it will host a conference call on Tuesday; February 25, 2014 at 8:30 a.m. E. T. to discuss its financial results for the year ended January 3, 2014.

Roundtable Top Picks for the Week of Jan. 20th - Video Blog
Panel Of Zacks Experts - Zacks Investment Research - Mon Jan 20, 3:43PM CST
Ideas for Chemicals, Financials and Medical Devices. Stocks covered include PPG Industries (PPG), Waddell & Reed (WDR) and Greatbatch Inc. (GB).

Greatbatch Shares Up 25.5% Since SmarTrend's Buy Recommendation (GB)
Comtex SmarTrend(R) - Fri Jan 17, 4:55PM CST
SmarTrend identified an Uptrend for Greatbatch (NYSE:GB) on October 16th, 2013 at $35.46. In approximately 3 months, Greatbatch has returned 25.51% as of today's recent price of $44.50.

Greatbatch, Inc. to Present at the 32nd Annual JP Morgan Healthcare Conference
Business Wire - Fri Jan 03, 12:58PM CST
Greatbatch, Inc. NYSE: (GB) announced today that Thomas J. Hook, president and CEO, will present at the JP Morgan Healthcare conference on January 16, 2014 at 11:30 a.m. PT.

22.5% Return Seen to Date on SmarTrend Greatbatch Call (GB)
Comtex SmarTrend(R) - Fri Jan 03, 9:44AM CST
SmarTrend identified an Uptrend for Greatbatch (NYSE:GB) on October 16th, 2013 at $35.46. In approximately 3 months, Greatbatch has returned 22.46% as of today's recent price of $43.42.

3 Stocks Near 52-Week Highs Worth Selling
Sean Williams, The Motley Fool - Motley Fool - Thu Jan 02, 3:23PM CST
The broad-based S&P 500 finished 2013 exactly as it began, on a high note with yet another record close, pushing the index up 30% for the year and sending 819 companies to a new 52-week high compared to just 71 new lows. For skeptics like me,...

Shares of GB Up 22.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Dec 27, 9:21AM CST
SmarTrend identified an Uptrend for Greatbatch (NYSE:GB) on October 16th, 2013 at $35.46. In approximately 2 months, Greatbatch has returned 22.87% as of today's recent price of $43.56.

Addition to Indices, and Stock Price Movements - Research Report on ACADIA Pharmaceuticals, InterMune, Tandem Diabetes Care, Nektar Therapeutics and Greatbatch
PR Newswire - Wed Dec 25, 7:00AM CST
Today, Analysts' Corner announced new research reports highlighting ACADIA Pharmaceuticals, Inc. (NASDAQ: ACAD), InterMune Inc. (NASDAQ: ITMN), Tandem Diabetes Care Inc (NASDAQ: TNDM), Nektar Therapeutics (NASDAQ: NKTR), and Greatbatch, Inc. (NYSE: GB). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Geothermal AI Nodes Take Aim at Stranded Well Power

Updated Category News Views 175

Millions of idle wells are sitting under America like unwanted basement clutter, and GEIOS GEOFLEX thinks some can become small, self-contained AI power plants. That is the provocative idea behind its Dark Token Factory partnership with Aiden Digital Labs: bolt an autonomous compute module onto an abandoned or non-producing oil and gas well, pull geothermal heat from...

Continue Reading
Clickstop's Urbana Expansion Bets on Durable Demand

Updated Category News Views 63

A patch of turned Iowa dirt can say plenty about a company’s nerve. Clickstop broke ground in Urbana on Nov. 19, 2026, for a 43,000-square-foot building, and the message is pretty plain: management believes its recent growth has legs. For a privately held, employee-owned operator serving trucking, construction, lifting and rigging, that is not a casual decision....

Continue Reading
Cineverse Sets Wolf Creek Return for March 19, 2027

Updated Category News Views 121

A sunburned serial killer is heading back to theaters, and Cineverse has finally put a date on it: March 19, 2027. WOLF CRE3K, formerly called Wolf Creek: Legacy, brings John Jarratt back as Mick Taylor for the third film in the Australian horror franchise. For NASDAQ:CNVS investors, this is not the kind of announcement that lets anyone pencil in revenue with a straight...

Continue Reading
DHC’s Ulta Rollout Gets a Useful Pricing Correction

Updated Category News Views 49

A face-wash price tag just became the most revealing part of DHC’s Ulta expansion. The company corrected an earlier announcement that had listed its new Deep Cleansing Face Wash at $31.50; the actual price is $19.00. That may sound like tiny housekeeping, and in the grand scheme it is, but consumer brands live or die on this kind of detail. A cleanser priced near $20...

Continue Reading
Hard Rock Tampa Bets $30 Million on Smoke-Free Play

Updated Category News Views 71

Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...

Continue Reading
IT Tech Packaging's Going-Concern Warning Lands Hard

Updated Category News Views 91

A paper maker can survive plenty of ugly quarters; it cannot casually shrug off an auditor questioning whether it can keep operating. That is the cold part of IT Tech Packaging's Nov. 19 disclosure. Its newly filed Form 10-K for the year ended Dec. 31, 2025 carries a “Material Uncertainty Related to Going Concern” paragraph from Audit Alliance LLP. Nobody should dress...

Continue Reading
Barcelona Housing Summit Puts Affordability on the Map

Updated Category News Views 186

A packed Barcelona hall cannot magically unjam a housing market, but it can force the grown-ups in the room to stare at the mess. Housing World Summit, known as HOWS Barcelona, closed its first edition with 1,530 attendees and a broad cast: city officials, governments, developers, investors, third-sector groups and academics. That mix matters because affordable housing is...

Continue Reading
Decibel's Export Engine Masks a Domestic Sales Slip

Updated Category News Views 87

Decibel’s overseas business is doing the heavy lifting, and it is not doing it quietly. Third-quarter net revenue reached $35.1 million, up 7% from a year earlier, while international sales jumped 44% to a record $12.1 million. That split matters more than the headline. Canadian adult-use sales fell 6% to $23.0 million, which means the company is proving it can find...

Continue Reading
SciBase Sets Its 2027 AGM Nominating Committee Early

Updated Category News Views 94

Four names on a committee roster rarely make anyone pound the table, and they should not. Still, SciBase Holding has put an important bit of corporate housekeeping in place for its 2027 Annual General Meeting: the nominating committee that will handle shareholder-facing governance work ahead of the May 20 meeting in Stockholm. For a small listed medical-technology...

Continue Reading
JDEnergy's RE+ Push Meets a Grid Hungry for Storage

Updated Category News Views 64

Certification Is Useful, Not a Victory Lap A battery box earning a safety certificate is not usually thrilling stuff, but the timing matters here. On Nov. 19, 2026, JDEnergy laid out its North American storage pitch at RE+ in Las Vegas while electricity demand is getting shoved higher by industrial buildout and AI data centers. Add more variable renewable generation to an...

Continue Reading

Top 5 Most Recently Viewed Articles

McDonald's Earnings Anticipation: Insights from Analysts Ahead

Updated Category News Views 110

Anticipating McDonald's Q3 Earnings Report As the third quarter approaches, McDonald's Corporation (NYSE: MCD) is preparing to unveil its earnings report, sparking interest among investors and analysts alike. This significant event is anticipated to occur just before the opening bell, offering crucial insights into the company's financial health and market position. What...

Continue Reading
BC Platforms Unveils Game-Changing AI Technology for Researchers

Updated Category News Views 281

BC Platforms Introduces BC Catalyst for Precision Medicine BC Platforms has officially launched BC Catalyst, an innovative AI-native analytics product designed to enhance precision medicine. This breakthrough technology integrates genomic and real-world data, allowing for actionable insights throughout the entire drug lifecycle. With BC Catalyst, the company aims to...

Continue Reading
TestFly Expands QA Testing Services with Red Cerberus Deal

Updated Category News Views 300

TestFly Enhances Service Offerings Through Acquisition TestFly, a prominent provider of innovative quality assurance testing solutions for the video game and mobile gaming sectors, has undertaken a significant move by acquiring Red Cerberus. This acquisition is set to transform the landscape of video game quality assurance by integrating Red Cerberus' expertise and...

Continue Reading
Unveiling Insurance Industry Abuses: New Podcast Series Launch

Updated Category News Views 173

Consumer Watchdog Introduces Insightful Podcast Series Smoke & Mirrors Debuts Today, Investigating Insurance Underpayments and Consumer Resilience Today marks the launch of a groundbreaking podcast series from Consumer Watchdog, titled "Smoke & Mirrors: Investigating Home Insurance Abuses," aimed at shedding light on the troubling practices that major insurance firms...

Continue Reading
MongoDB’s Leadership Change: Opportunities for Investors Ahead

Updated Category News Views 171

Understanding the Leadership Shift at MongoDB Recently, MongoDB (NASDAQ: MDB) has been a significant topic of discussion in investing circles due to its remarkable stock performance. After the stock's impressive rise from $188.81 to about $358 per share, many are questioning the right strategy—should investors lock in their profits now or remain committed for the long...

Continue Reading